CIK: 0001440771 · Show all filings
Period: Q2 2018 (← Previous) (Next →)
Filing Date: Aug 14, 2018
Total Value ($000): $164,570 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | BIOSPECIFICS TECHNOLOGIES | 461,315 | $20,695 | 12.6% | $45.13 | — | COM | 090931106 |
| — | CTI BIOPHARMA CORP | 4,049,298 | $20,166 | 12.3% | $3.59 | — | COM | 12648L601 |
| — | APOLLO ENDOSURGERY INC | 2,577,996 | $17,994 | 10.9% | $4.75 | — | COM | 03767D108 |
| — | AMARIN CORP PLC -ADR | 5,670,205 | $17,521 | 10.6% | $3.01 | — | SPONS ADR NEW | 023111206 |
| VNDA | VANDA PHARMACEUTICALS INC | 600,000 | $11,430 | 6.9% | $14.90 | +12.2% | COM | 921659108 |
| — | VIVEVE MEDICAL INC | 3,849,711 | $10,471 | 6.4% | $6.92 | — | COM NEW | 92852W204 |
| CPIX | CUMBERLAND PHARMACEUTICALS | 1,203,339 | $7,376 | 4.5% | $5.83 | +7.4% | COM | 230770109 |
| — | CORREVIO PHARMA CORP | 1,930,022 | $7,295 | 4.4% | $3.78 | — | COM | 22026V105 |
| — | ALIMERA SCIENCES INC | 6,981,184 | $6,830 | 4.2% | $1.18 | — | COM | 016259103 |
| — | NOVELION THERAPEUTICS INC | 1,792,911 | $6,598 | 4.0% | $8.14 | — | COM NEW | 67001K202 |
| — | HTG MOLECULAR DIAGNOSTICS | 1,689,064 | $5,506 | 3.3% | $3.26 | — | COM | 40434H104 |
| — | OPHTHOTECH CORP | 1,912,018 | $5,220 | 3.2% | $4.11 | — | COM | 683745103 |
| — | BIODELIVERY SCIENCES INTL | 1,486,002 | $4,384 | 2.7% | $2.06 | — | COM | 09060J106 |
| — | RIGEL PHARMACEUTICALS INC | 1,496,590 | $4,235 | 2.6% | $2.83 | — | COM NEW | 766559603 |
| ADMA | ADMA BIOLOGICS INC | 831,731 | $3,751 | 2.3% | $4.98 | 0.0% | COM | 000899104 |
| ACAD | ACADIA PHARMACEUTICALS INC | 194,900 | $2,976 | 1.8% | $17.83 | 0.0% | COM | 004225108 |
| ATEC | ALPHATEC HOLDINGS INC | 903,224 | $2,692 | 1.6% | $3.55 | 0.0% | COM NEW | 02081G201 |
| — | CATABASIS PHARMACEUTICALS IN | 2,400,000 | $2,302 | 1.4% | $0.96 | — | COM | 14875P107 |
| — | CIDARA THERAPEUTICS INC | 425,531 | $2,213 | 1.3% | $5.20 | — | COM | 171757107 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 198,373 | $1,393 | 0.8% | $9.81 | 0.0% | COM | 87164F105 |
| — | CANCER GENETICS INC | 1,391,607 | $1,239 | 0.8% | $1.85 | — | COM | 13739U104 |
| — | GEMPHIRE THERAPEUTICS INC | 103,000 | $1,050 | 0.6% | $6.51 | — | COM | 36870A108 |
| — | CONFORMIS INC | 616,109 | $770 | 0.5% | $1.45 | — | COM | 20717E101 |
| — | MELINTA THERAPEUTICS INC | 52,200 | $331 | 0.2% | $6.34 | — | COM | 58549G100 |
| — | INVIVO THERAPEUTICS HOLDINGS | 77,900 | $132 | 0.1% | $1.69 | — | COM PAR | 46186M407 |